Pediatrix Medical Group, Inc. (MD) Stock

About Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. (MD) stock trades at $29.29 with a market capitalization of $2.38B. The stock is valued at a price-to-earnings (P/E) ratio of 12.31, price-to-book of 2.34, price-to-sales of 1.09. Over the past 52 weeks the stock has ranged between $15.70 and $29.64, and currently trades 1.2% below its 52-week high.

On profitability, Pediatrix Medical Group, Inc. generates a return on equity (ROE) of 19.89%, above the typical market range of roughly 12-15%, return on capital employed of 13.89%, an operating margin of 12.07%, a net profit margin of 8.96%.

Pediatrix Medical Group, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Pediatrix Medical Group, Inc. reported revenue of $3.2B rising to $1.9B, a change of -39.9% across 10 years. Compounded, revenue has grown 2.0% a year over five years, -1.0% over three, -4.9% over the last twelve months. Net profit fell to $165.0M.

Operating margin went from 18.0% in 2016 to 12.1% in 2025, a fall of 5.9 percentage points. The most recent net margin is 8.96%. On a trailing twelve-month basis to Jun '26, revenue is $2.0B and net profit $176.0M.

Borrowings fell from $1.7B to $660.0M, cash from operations was $271.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged 4.2% over five years, and was 19.1% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Pediatrix Medical Group, Inc. (MD) — frequently asked questions